Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Market Cap	1.31B -51.5%
Revenue (ttm)	2.70B -7.7%
Net Income	14.17M -94.3%
EPS	0.26 -94.3%
Shares Out	55.21M
PE Ratio	91.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,382
Open	24.13
Previous Close	24.13
Day's Range	23.61 - 24.95
52-Week Range	15.20 - 52.50
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 28, 2026

About Balaxi Pharmaceuticals

Balaxi Pharmaceuticals Limited, through its entity Balaxi Ventures Ltd., primarily operates as an international wholesale distributor specializing in pharmaceuticals, various food items, and hardware supplies. The company's corporate base is situated in Hyderabad, Telangana. Its extensive product range features pharmaceutical formulations, a variety of food products, and construction-related hardware. Notably, both its pharmaceutical and builders' hardware offerings are manufactured under contract at different plants located across India. Withi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BALAXI

Financial Performance

In fiscal year 2026, Balaxi Pharmaceuticals's revenue was 2.70 billion, a decrease of -7.65% compared to the previous year's 2.93 billion. Earnings were 14.17 million, a decrease of -94.35%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error